Brief: Shield Therapeutics Says Total Q3 2023 U.S. Net Revenue Of $4.1 MLN
07/12/2023 07:49
Dec 7 (Reuters) - Shield Therapeutics PLC STXS.L :
* TOTAL Q3 2023 U.S. NET REVENUE OF $4.1 MILLION
Source text for Eikon: ID:nRSG9272Va
Further company coverage: STXS.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shield Therapeutics
See all newsBrief: Shield Therapeutics To Assume Full Commercial Control Of ACCRUFeR In US
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
Shield Therapeutics - Interim results for the six months ended 30 Jun 26
Brief: Shield Therapeutics Says On Track For Profitability In 2026; Appoints Michael Jensen As CFO
Shield Therapeutics - Q2 and H1 2026 Trading Update